These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1499611)

  • 1. Penile revascularization in nonresponders to intracavernous injections using a modified microsurgical technique.
    Löbelenz M; Jünemann KP; Köhrmann KU; Seemann O; Rassweiler J; Tschada R; Alken P
    Eur Urol; 1992; 21(2):120-5. PubMed ID: 1499611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Revascularization of the penis in vascular-induced erectile dysfunction: clinical results of the Hauri surgical method].
    Zumbé J; Westerdorf G; Kierfeld G
    Urologe A; 1988 Nov; 27(6):336-9. PubMed ID: 3070900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsurgical arterio-arterial and arterio-venous penile revascularization in patients with pure arteriogenic impotence.
    Janssen T; Sarramon JP; Rischmann P; Bennis S; Malavaud B
    Br J Urol; 1994 May; 73(5):561-5. PubMed ID: 8012780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y; Lidgi S; Moskovitz B; Levin RD
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction.
    Montorsi F; Guazzoni G; Bergamaschi F; Ferini-Strambi L; Barbieri L; Rigatti P
    J Urol; 1993 May; 149(5 Pt 2):1291-5. PubMed ID: 7683061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
    von Heyden B; Donatucci CF; Kaula N; Lue TF
    J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The success of microsurgical penile revascularization in treating arteriogenic impotence.
    Melman A; Riccardi R
    Int J Impot Res; 1993 Mar; 5(1):47-52. PubMed ID: 8348213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
    Lee LM; Stevenson RW; Szasz G
    J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
    Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
    J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of male organic impotence of vascular origin].
    Proca E; Sinescu I
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1990; 39(1):21-35. PubMed ID: 2149189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
    Engel JD; McVary KT
    Urology; 1998 May; 51(5):687-92. PubMed ID: 9610580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
    Sidi AA; Cameron JS; Duffy LM; Lange PH
    J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsurgical arteriovenous revascularization in the treatment of vasculogenic impotence.
    Schramek P; Engelmann U; Kaufmann F
    J Urol; 1992 Apr; 147(4):1028-31. PubMed ID: 1532427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsurgical penile revascularization using the central corporeal penile artery.
    Konnak JW; Ohl DA
    J Urol; 1989 Aug; 142(2 Pt 1):305-8. PubMed ID: 2746748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of venous leakage: medium-term follow-up.
    McLoughlin J; Asopa R; Williams G
    Eur Urol; 1993; 23(3):352-6. PubMed ID: 8508886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
    Fu Q; Yao DH; Jiang YQ
    Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.